JSGRX
Price
$27.36
Change
-$0.62 (-2.22%)
Updated
Feb 21 closing price
Net Assets
1.71B
RGAGX
Price
$76.88
Change
-$1.85 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

JSGRX vs RGAGX

Header iconJSGRX vs RGAGX Comparison
Open Charts JSGRX vs RGAGXBanner chart's image
JHancock U.S. Growth R2
Price$27.36
Change-$0.62 (-2.22%)
VolumeN/A
Net Assets1.71B
American Funds Growth Fund of Amer R6
Price$76.88
Change-$1.85 (-2.35%)
VolumeN/A
Net Assets304.33B
JSGRX vs RGAGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSGRX vs. RGAGX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGRX is a Buy and RGAGX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 304B vs. JSGRX (1.71B). RGAGX pays higher dividends than JSGRX: RGAGX (0.75) vs JSGRX (0.00). JSGRX was incepted earlier than RGAGX: JSGRX (10 years) vs RGAGX (16 years). JSGRX is a more actively managed with annual turnover of: 103.00 vs. RGAGX (31.00). JSGRX has a lower initial minimum investment than RGAGX: JSGRX (0) vs RGAGX (250). RGAGX annual gain was more profitable for investors over the last year : 12.78 vs. JSGRX (9.70). RGAGX return over 5 years is better than : 44.25 vs. JSGRX (34.05).
JSGRXRGAGXJSGRX / RGAGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years16 years-
Gain YTD2.2043.12571%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B304B1%
Annual Yield % from dividends0.000.75-
Returns for 1 year9.7012.7876%
Returns for 3 years23.8624.0499%
Returns for 5 years34.0544.2577%
Returns for 10 yearsN/A75.55-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAIR0.35-0.01
-1.49%
Beyond Air
SAP282.99-4.93
-1.71%
SAP SE
BCRX9.21-0.18
-1.92%
BioCryst Pharmaceuticals
ALT6.43-0.20
-3.02%
Altimmune
MASI169.96-7.25
-4.09%
Masimo Corp